Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Henry

Showing results (481-490 of 579) with videos related to

Pageof 58
Sort By:
Journal of Magnetic Resonance Imaging : JMRI|September 15, 2005
Heterogeneity in the angiogenic response of a BT474 human breast cancer to a novel vascular endothelial growth factor-receptor tyrosine kinase inhibitor: assessment by voxel analysis of dynamic contrast-enhanced MRIKa-Loh Li, Lisa J Wilmes, Roland G Henry, et al.
Journal of General Internal Medicine|October 4, 2023
Impact of 30-day prescribed opioid dose trajectory on fatal overdose risk: A population-based, statewide cohort studyStephen G Henry, Shao-You Fang, Andrew J Crawford, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 13, 2025
LRRK2 as a Potential Disease-Modifying Target in Sporadic Parkinson's DiseaseAnthony E Lang, Robert A Hauser, Lorraine V Kalia, et al.
Journal of the American Dental Association (1939)|February 26, 1999
Alzheimer's disease, dental amalgam and mercuryS R Saxe, M W Wekstein, R J Kryscio, et al.
Scientific Reports|June 19, 2021
Understanding LRRK2 kinase activity in preclinical models and human subjects through quantitative analysis of LRRK2 and pT73 Rab10Xiang Wang, Elvira Negrou, Michael T Maloney, et al.
The International Journal on Drug Policy|January 23, 2025
How do restrictions on opioid prescribing, harm reduction, and treatment coverage policies relate to opioid overdose deaths in the United States in 2013-2020? An application of a new state opioid policy scaleSamantha M Doonan, Katherine Wheeler-Martin, Corey Davis, et al.
Epidemiology (Cambridge, Mass.)|October 10, 2019
Measuring Relationships Between Proactive Reporting State-level Prescription Drug Monitoring Programs and County-level Fatal Prescription Opioid OverdosesMagdalena Cerdá, William R Ponicki, Nathan Smith, et al.
Brain Communications|November 29, 2024
Spinal cord evaluation in multiple sclerosis: clinical and radiological associations, present and futureB Mark Keegan, Martina Absinta, Julien Cohen-Adad, et al.
Neuroimage. Clinical|February 26, 2021
Multimodal MRI staging for tracking progression and clinical-imaging correlation in sporadic Creutzfeldt-Jakob diseaseSimone Sacco, Matteo Paoletti, Adam M Staffaroni, et al.
Annals of Neurology|September 6, 2019
Telomere Length Is Associated with Disability Progression in Multiple SclerosisKristen M Krysko, Roland G Henry, Bruce A C Cree, et al.
Pageof 58

Showing results (481-490 of 579) with videos related to

Sort By:
Pageof 58
Journal of Magnetic Resonance Imaging : JMRI|September 15, 2005
Heterogeneity in the angiogenic response of a BT474 human breast cancer to a novel vascular endothelial growth factor-receptor tyrosine kinase inhibitor: assessment by voxel analysis of dynamic contrast-enhanced MRIKa-Loh Li, Lisa J Wilmes, Roland G Henry, et al.
Journal of General Internal Medicine|October 4, 2023
Impact of 30-day prescribed opioid dose trajectory on fatal overdose risk: A population-based, statewide cohort studyStephen G Henry, Shao-You Fang, Andrew J Crawford, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 13, 2025
LRRK2 as a Potential Disease-Modifying Target in Sporadic Parkinson's DiseaseAnthony E Lang, Robert A Hauser, Lorraine V Kalia, et al.
Journal of the American Dental Association (1939)|February 26, 1999
Alzheimer's disease, dental amalgam and mercuryS R Saxe, M W Wekstein, R J Kryscio, et al.
Scientific Reports|June 19, 2021
Understanding LRRK2 kinase activity in preclinical models and human subjects through quantitative analysis of LRRK2 and pT73 Rab10Xiang Wang, Elvira Negrou, Michael T Maloney, et al.
The International Journal on Drug Policy|January 23, 2025
How do restrictions on opioid prescribing, harm reduction, and treatment coverage policies relate to opioid overdose deaths in the United States in 2013-2020? An application of a new state opioid policy scaleSamantha M Doonan, Katherine Wheeler-Martin, Corey Davis, et al.
Epidemiology (Cambridge, Mass.)|October 10, 2019
Measuring Relationships Between Proactive Reporting State-level Prescription Drug Monitoring Programs and County-level Fatal Prescription Opioid OverdosesMagdalena Cerdá, William R Ponicki, Nathan Smith, et al.
Brain Communications|November 29, 2024
Spinal cord evaluation in multiple sclerosis: clinical and radiological associations, present and futureB Mark Keegan, Martina Absinta, Julien Cohen-Adad, et al.
Neuroimage. Clinical|February 26, 2021
Multimodal MRI staging for tracking progression and clinical-imaging correlation in sporadic Creutzfeldt-Jakob diseaseSimone Sacco, Matteo Paoletti, Adam M Staffaroni, et al.
Annals of Neurology|September 6, 2019
Telomere Length Is Associated with Disability Progression in Multiple SclerosisKristen M Krysko, Roland G Henry, Bruce A C Cree, et al.
Pageof 58